Leukemia Clinical Trials

Showing 2741-2760 of 5,235 trials

Mobile Phone Daily Alarm To Improve Compliance Of Intranasal Corticosteroid Among Allergic Rhinitis Patients.

NCT05286944

This is a randomized controlled trial to compare the compliance of allergic rhinitis patients towards intranasal steroids between those who use mobile daily alarm reminder and those who do not.

Rhinitis, AllergicCompliance, Medication

National University of Malaysia207 participantsStarted Jan 2020

Kuala Lumpur, WP Kuala Lumpur, Malaysia

UNKNOWNPhase 1/2

TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung Cancer

NCT05284994

TQ-B3525 tablet is a new α/δ dual inhibitor phosphatidylinositol 3-kinase inhibitor developed by Chia Tai Tianqing pharmaceutical Group Co., Ltd. It can overcome the drug resistance problem caused by the up-regulation of phosphatidylinositol 3-kinase α subunit activity caused by the single inhibition of phosphatidylinositol 3-kinase δ subunit. This study is a single-arm, open-label, multi-cohort, multi-center clinical study of the safety and efficacy of TQ-B3525 tablets combined with osimertinib in subjects with advanced non-small cell lung cancer, aiming to evaluate TQ-B3525 tablets combined with osimertinib, the safety, tolerability, and efficacy of the treatment of patients with advanced non-small cell lung cancer who have failed epidermal growth factor receptor inhibitor therapy, while exploring the efficacy, resistance mechanism, and safety in the dose escalation phase biomarkers.

Nonsmall-cell Lung Cancer

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.160 participantsStarted Mar 2022

Guangzhou, Guangdong, China • Guangzhou, Guangdong, China • Guangzhou, Guangdong, China +6 more locations

Mobile Phone Daily Alarm To Improve Compliance Of Intranasal Corticosteroid Among Allergic Rhinitis Patients.

TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung Cancer

Related Searches

CDIAG Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Intervention to Improve Quality of Sleep of Palliative Patient Carers in the Community: Clinical Trial

Nilotinib for First-line Newly Diagnosed CML-CP Patients

Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)

An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia

Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy

IMRT-TMI With Fludarabine as Myeloablative Conditioning for Allogeneic HSCT

CAR-T-19 Cells for Patients With CD19+ Relapse/Refractory B-ALL

Allograft Reconstruction of Massive Rotator Cuff Tears vs Partial Repair Alone

Comparison of Postoperative Nociception Between NOL-guided and Standard Intraoperative Analgesia Based on Fentanyl

EBV-TCR-T Cells for EB Virus Infection After HSCT

Microtransplantation Combined With Azacytidine to Improve the Efficacy of EAML

Overcoming Geography With Technology: Medical Drones Project

Phase II Study on Sintilimab Combined With Docetaxel for Chemotherapy Failure Advanced NSCLC: the SUCCESS Study

Fruquintinib Combined With Sintilimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer

Immediate Loading of Implants in the Partially or Completely Edentulous Jaw

The Dysbiosis of the Intestinal Microbiota in Individuals With Allergic Rhinitis (MICRORIN)

Appropriate Dosing to Optimise Personalised Cancer Treatments